Valuation
- Market cap
- 20,191,000
- Revenue TTM
- $1,620,000
- Net income TTM
- $-12,660,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -781.48%
- Debt to equity
- 0.00
Trading
- Volume
- 52,500
- Avg volume
- 48,674
- Day's range
- $5.40 – $6.00
- Shares out
- 3,394,000
- Stochastic %K
- 87%
- Beta
- 1.35
- Analysts
- Hold
- Price target
- $3.00
Company profile
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in dr...
Show more
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
- Industry
- Software - Infrastructure
- Sector
- Technology
- Phone
- 412 432 1500
- Website
- https://predictive-oncology.com
- Address
- 91 43rd Street, Suite 110, Pittsburgh, United States
Latest news
No headlines yet.
